Interview with Peter Rothschild regarding results of Year-end report 2015

Peter Rothschild, President of BioGaia, summarises 2015 and answers questions regarding;

• reasons behind a weaker trend during the fourth quarter
• any possible factors that may affect sales during the upcoming year
• what needs to be accomplished in order to reach doubel-digit growth also the next year
• the proposed listing of subsidary IBT and the progress they are making in developing a new drug against NEC
• expectations, oportunities and challenges for the upcoming year